Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1

Conditions

Venous Thromboembolism 4Venous Thrombosis 2Pulmonary Embolism 2Neoplasms 2Vulvar Neoplasms 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Thrombosis 1Thromboembolism 1Sarcoma 1Ovarian Neoplasms 1Lung Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Endometrial Neoplasms 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Brachytherapy 4fludarabine phosphate 3Radiotherapy 3Radiosurgery 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3fludarabine 2aldesleukin 2aflibercept 2Vaccines, Synthetic 2Trastuzumab 2Topotecan 2Therapeutics 2Surveys and Questionnaires 2Psychiatric Rehabilitation 2Paclitaxel 2Methods 2Magnetic Resonance Spectroscopy 2Early Intervention, Educational 2Cyclophosphamide 2Counseling 2Cisplatin 23-aminopyridine-2-carboxaldehyde thiosemicarbazone 2tremelimumab 1tipifarnib 1temsirolimus 1entinostat 1durvalumab 1alovudine 1Vinorelbine 1Vaccines 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Vaginal Neoplasms × Fondaparinux × Clear all
NCT00381888 2017-12-28

Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer

Masonic Cancer Center, University of Minnesota

Phase 2 Completed
44 enrolled 7 charts
GynecologicSarcoma

Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Sarcoma, Thromboembolism, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡